Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Tidmarsh’s CDER Exit Creates More Instability, Uncertainty For US FDA, Industry
Nov 04 2025
•
By
Sarah Karlin-Smith
The potential departure of relatively new CDER leader George Tidmarsh is throwing FDA and industry off balance.
(Shutterstock)
Explore how consumer health is evolving. On the go.
David Ridley hosts in-depth conversations with industry leaders.
More from Leadership
More from HBW Insight